MedTrace Logo

Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women

NCT07521163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2026-07-16

No results posted yet for this study

Summary

This study evaluated the effect of a Health Belief Model-based educational intervention on women's knowledge of cervical cancer and their attitudes and beliefs toward HPV vaccination. The study was conducted among women aged 18-49 years attending a primary health care center in Van, Türkiye. Participants were assigned to intervention and control groups. The intervention group received a structured, face-to-face educational program, while the control group received routine care. Data were collected using validated questionnaires before and after the intervention. The findings contributed to a better understanding of strategies to improve preventive health behaviors and increase HPV vaccination awareness among women.

Conditions

  • Cervical Cancer
  • Human Papillomavirus Infection
  • Preventive Health Services

Interventions

BEHAVIORAL

Health Belief Model-Based Education

A structured face-to-face educational program based on the Health Belief Model consisting of two sessions (30-40 minutes each) covering cervical cancer, HPV infection, cervical cancer screening, HPV vaccination, common misconceptions, and the key Health Belief Model constructs, including perceived susceptibility, perceived severity, perceived benefits, and perceived barriers.

Sponsors & Collaborators

  • Muhammet Faruk Yigit

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2026-04-15
Completion
2026-05-12

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07521163 on ClinicalTrials.gov